NORTH CHICAGO, Ill., May 10, 2018 /PRNewswire-USNewswire/ -- Rosalind Franklin University of Medicine
"We're realigning our research strengths around core areas of scientific expertise with the goal of fostering innovation to help move our research out of the lab and into the marketplace to improve human health," said Dr. K. Michael Welch, RFU president and CEO.
The new centers, along with the new Brain Science Institute and its three supporting centers announced by the university in February will be housed in the Innovation and Research Park, now under construction on RFU's campus. Expected to open in summer 2019, the space is designed to spur creative collaboration among academic and industry scientists, innovators and entrepreneurs.
"We're recognizing both our own areas of research strength as well as significant bioscience industry interest in developing new diagnostics and therapeutics in genetic diseases, cancer and protein-based therapies and biomarkers," said Ronald Kaplan, RFU executive vice president for research. "This realignment positions us to partner more effectively with industry to achieve important advancements in patient care and wellness."
The three newest RFU research centers and their directors, include:
About Rosalind Franklin UniversityFormed in 1912 as the Chicago Hospital-College of Medicine, Rosalind Franklin University of Medicine and Science is a national leader in interprofessional medical and healthcare education and biomedical research. RFU includes the Chicago Medical School, School of Graduate and Postdoctoral Studies, College of Health Professions, Dr. William M. Scholl College of Podiatric Medicine and College of Pharmacy. More than 18,000 RFU degreed alumni are active throughout the United States and around the world. Learn more at rosalindfranklin.edu
Office of Marketing and Communicationsjudy.email@example.com
View original content:http://www.prnewswire.com/news-releases/new-research-centers-created-by-rosalind-franklin-university-300646593.html
SOURCE Rosalind Franklin University of Medicine and Science
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All